Hepatitis D Clinical Trials
34 clinical trials for Hepatitis D across international registries, including 9 currently recruiting participants. Compare status, phase, eligibility criteria and locations.
- Evaluation of Patients With Liver Disease — RECRUITING
- Oral-Periodontal Evaluation and Assessment of Oral Fluid Biomarkers in Patients With Hepatitis B+D — RECRUITING
- Immunological and Virological Characterization of Patients With Chronic HBV-HDV Infection: Outcomes and Response to Bulevirtide Treatment — RECRUITING
- DELTA DESCRIBE: the French Collaborative Project — RECRUITING
- A GLOBAL, RANDOMIZED, OPEN-LABEL, MULTICENTER, PHASE 2B/3 TRIAL EVALUATING BJT-778 VS DELAYED TREATMENT FOR THE TREATMENT OF CHRONIC HEPATITIS DELTA INFECTION (AZURE-1) — RECRUITING · PHASE2
- A PHASE 3 RANDOMIZED, OPEN-LABEL STUDY TO EVALUATE THE EFFICACY AND SAFETY OF TOBEVIBART+ELEBSIRAN COMBINATION THERAPY IN PARTICIPANTS WITH CHRONIC HDV INFECTION (ECLIPSE 1) — RECRUITING · PHASE3
- Effectiveness and Safety of Bulevirtide (BLV) Therapy in Patients With Chronic Hepatitis Delta (CHD) in Italy (D-SHIELD) — RECRUITING
- Effectiveness and Clinical Outcomes of Long-term Bulevirtide Monotherapy in Patients With HDV-related Compensated Cirrhosis — RECRUITING
- Standardising Care for Hepatitis Delta in the Netherlands — RECRUITING
- Study of ARC-520 With or Without Other Drugs Used in the Treatment of Chronic Chronic Hepatitis B Virus (HBV) — TERMINATED · PHASE2
- A Clinical Trial of Hepalatide for Injection in Patients With Chronic Hepatitis D — ACTIVE_NOT_RECRUITING · PHASE2
- A Study to Assess the Safety, Tolerability and Pharmacokinetics of ABI-6250 in Healthy Participants — COMPLETED · PHASE1
- Improvement of Portal Hypertension During Viral Suppression in Patients With Hepatitis Delta (IMPHROVE-D) — ACTIVE_NOT_RECRUITING
- Community Screening and Management of Hepatitis B, C and Delta in the Mongolian Population Living in France — NOT_YET_RECRUITING · NA
- HDV-Europe: Prevalence and Outcome of HDV in HIV/HBV Coinfection — OTHER
- Prevalence and Clinical Characterization of Hepatitis D Virus (HDV) Infection Among Sudanese Patients With Hepatitis B Virus — COMPLETED
- Efficacy and Safety of Bulevirtide (BLV) Therapy in HDV Chronic Hepatitis (CHD) in Italy — COMPLETED
- HEllenic Multicenter ReAl-life CLInical Study for Bulevirtide Therapy in Chronic Hepatitis D: HERACLIS-BLV — OTHER
- Epidemiology of Hepatitis B, C and D and HIV Along the Maroni River Bordering French Guiana and Suriname (MaHeVi) — COMPLETED
- A Study to Compare P1101 Plus TAF With or Without UDCA in Patients With HBV and HDV Co-Infection — OTHER · PHASE2
- A Study of Safety and Efficacy of ATI-2173 in Combination With Tenofovir Disoproxil Fumarate in Subjects With Chronic Hepatitis B Virus Infection and in Subjects With Hepatitis D Virus Coinfection — TERMINATED · PHASE2
- Prevalence and Burden of Hepatitis D Virus Infection in China Through Preoperative Examination Test (Predict Study) — OTHER
- Registry-based Study in Patients With Hepatitis D Virus (HDV) Infection in China — NOT_YET_RECRUITING
- The Hepatitis Delta International Network — COMPLETED
- Disease Loads and Status of Treatment — OTHER
- Treatment of Chronic Delta Hepatitis With Lonafarnib, Ritonavir and Lambda Interferon — COMPLETED · PHASE2
- A PHASE 3, MATRIX DESIGN, PARTIALLY DOUBLE-BLIND, RANDOMIZED STUDY OF THE EFFICACY AND SAFETY OF 50 MG LONAFARNIB / 100 MG RITONAVIR BID WITH AND WITHOUT 180 MCG PEG IFN-ALFA-2A FOR 48 WEEKS COMPARED WITH PEG IFN-ALFA-2A MONOTHERAPY AND PLACEBO TREATMENT IN PATIENTS CHRONICALLY INFECTED WITH HEPATITIS DELTA VIRUS BEING MAINTAINED ON ANTI-HBV NUCLEOS(T)IDE THERAPY (D-LIVR) — COMPLETED · PHASE3
- Treatment of Chronic Delta Hepatitis With Lonafarnib and Ritonavir — COMPLETED · PHASE2
- Epidemiology of Hepatitis B, C and Delta in Reunion Island — OTHER
- HIDIT II - PegIFN-alfa2a Plus Tenofovir in Chronic Delta Hepatitis — COMPLETED · PHASE2
- Mother-to-child Hepatitis D Transmission — COMPLETED
- Lonafarnib for Chronic Hepatitis D — COMPLETED · PHASE2
- Proof-of-concept Study Evaluating the Safety and Efficacy of EBP921 in Delta Hepatitis (HDV) — TERMINATED · PHASE1
- Pegylated Interferon to Treat Chronic Hepatitis D — COMPLETED · PHASE2
Refine this search